Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aardvark, Advantage, Agepha, Akebia, Aldeyra, Amarin, Amgen, Arcellx, Argenx, Aridis, ARS, Biologix, Boehringer Ingelheim, Geron, Pfizer, Precigen, Replay, Sonnet.